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Agrin Congenital Myasthenia
Huze et al., page 155
Myasthenia, or muscle weakness, is a primary component
of many congenital disorders. This weakness is widely
attributed to defects in the transmission of signals from
the nerve to the skeletal muscle and can be categorized on
the basis of the location of the defect. For example, myas-
thenia can be caused by presynaptic, synaptic, or postsyn-
aptic neuromuscular defects. Mutations in many genes
encoding synaptic receptors, ion channels, and membrane
structural proteins are known to be responsible for congen-
ital myasthenic syndromes (CMS); however, no mutations
have been reported in neural secreted factors. To date, the
underlying genetic defect in numerous CMS patients has
remained elusive. Here, Huze and colleagues identify a
homozygous missense mutation in AGRN in a family with
CMS. The mutation is inherited in an autosomal-recessive
manner. AGRN encodes the heparan sulfate proteoglycan
agrin, of which speciﬁc splice forms localize to the neuro-
muscular junction (NMJ). Neural agrin has been shown to
be important for acetacholine receptor (AChr) clustering
in model systems. Here, the authors ﬁnd that although
neural agrin localizes to NMJs in their patient, NMJ organi-
zation is abnormal. Surprisingly, AChR clustering is found
to be normal, as is a-dystroglycan binding. Several different
functional studies carried out in this study corroborate
these ﬁndings. Together, these data indicate a previously
undescribed role of agrin in NMJ maintenance and add
AGRN to the growing list of CMS-causative genes.
Skewed X Chromosome Inactivation and Trisomy
Warburton et al., page 179
During embryogenesis, X chromosome inactivation (XCI)
generally occurs randomly, such that approximately 50%
of cells contain an inactivematernal copy of the X chromo-
some and 50% of cells contain an inactive paternal copy.
There are situations inwhich the ratioof cellswithmaternal
copies to cells with paternal copies is skewed in one direc-
tion or the other. When this skewing is higher than 90%,
the XCI is considered highly skewed (highly skewed
X chromosome inactivation, or HSXI). In many studies,
HSXI has been associated with increased rates of recurrent
spontaneous abortions, but the reasons behind this rela-
tionship have not been completely elucidated, and incon-1Science Editor, AJHG; 2Deputy Editor, AJHG
DOI 10.1016/j.ajhg.2009.07.014. ª2009 by The American Society of Human
The Amersistent results have made it difﬁcult to make solid conclu-
sions. Although HSXI can occur at a small frequency as
a result of chance, selection against an abnormalX chromo-
some is thought to play a role inmany cases. A great deal of
work in female carriers of X-linked diseases has demon-
strated that skewing often results such that the abnormal
X chromosome is inactive in a higher percentage of cells.
It has therefore been hypothesized that the increased rate
of recurrent spontaneous abortions seen in cases of HSXI
maybedue to thehigh loss ofmale conceptions that inherit
the mutant X chromosome. However, it has been discov-
ered that only a low percentage of lost male conceptions
are chromosomally normal. In contrast, a large percentage
of pregnancy losses are trisomic. The presence of an
abnormal X chromosome has also been linked to a decrease
in the size of the oocyte pool, whichhas been hypothesized
to be at the root of the correlation between advanced
maternal age and increased risk for trisomic conceptions.
Warburton et al. predict that there is an underlying factor
that causes both the HSXI and trisomy. Therefore, the
authors sought to identify a correlation between HSXI
and trisomic conceptions. After carefully controlled anal-
yses, the authors conclude that there is no correlation
between trisomy and HSXI.
Human Variation in Host Response
Ko et al., page 214
Genetic variation is critical to the evolution of a species
because it provides the means for natural selection to take
place. Alterations in the genetic code may make one more
or less susceptible to a disease or infection and may thus
be selected for or against over time. Variants in the human
genome are currently under close scrutiny for association
with awide variety of complex diseases, including diabetes,
heart disease, and schizophrenia. Another aspect of genetic
variation is the potential of a variant to alter a response to
a pathogen such as Pneumocystis or Salmonellae. How-
ever, unlike genome-wide association studies (GWAS) for
common diseases, not many studies have yet identiﬁed
genes associated with infection. In this issue, Ko et al. use
an in vitro assay, which they devised, to screen for genes
involved in bacterial infection. Using Hi-HOST, Ko and
colleagues measure bacterial invasion, host cell death, and
host cytokine production after infection of HapMap lym-
phoblastoid cells with S. typhimurium. Correlating theirGenetics. All rights reserved.
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ﬁndings with GWAS data on these same cells, the authors
ﬁnd an association between a variant inCARD8 and Salmo-
nella-induced cell death. CARD8modiﬁes caspase-1, which
the authors correlate with Salmonella-induced cell death,
bringing the story full circle. Further investigation of the
CARD8 variant in different human andnonhuman popula-
tions reveals that this variant probably arose via adaptive
evolution. Finally, the authors ﬁnd the derived CARD8
allele more often in patients with systemic inﬂammatory
response syndrome (SIRS) than in healthy controls, impli-
cating this variant in susceptibility to acute inﬂammatory
disease as well.
X Chromosome Association with Progression
to AIDS
Siddiqui et al., page 228
Acquired immunodeﬁciency syndrome, or AIDS, is a
pandemic condition affecting people worldwide. Suffering
from a syndrome caused by infection with human immu-
nodeﬁciency virus (HIV), AIDS patients suffer from a failing
immune system that often culminates in death due to
opportunistic infection or cancer attributed to the deple-
tion of CD4þ T helper lymphocytes. Genetic differences
in CCR5 have been shown to inﬂuence a person’s suscepti-
bility to HIV infection. Likewise, geneticsmay play a role in
HIV progression to AIDS. In fact, studies have associated
variants in the MHC locus with the viral load of HIV
tolerated and with the rate of disease progression. These
associations may differ as a result of ethnic (i.e., genetic)
background. Rhesus macaques have long been used as
animalmodels forHIVpathology andvaccine trials because
they canbecome infectedwith themonkeyHIVequivalent,
simian immunodeﬁciency virus (SIV). However, little is
known about genetic similarities of HIV and SIV infection
and disease progression between macaques and humans.
Here, Siddiqui and colleagues perform a genome-wide asso-
ciation study for AIDS-free survival of SIV-infected
macaques and follow up their ﬁndings in humans. In addi-
tion to conﬁrming the association of AIDS progression and136 The American Journal of Human Genetics 85, 135–136, AugustMHCvariants in themonkeys, thisgroupidentiﬁesavariant
on the X chromosome that is protective against AIDS
disease progression. They conﬁrm this ﬁnding in humans
and ﬁnd that the variant is more prevalent among Asian
women than among European or African women, which
probably provides this ethnic group with a selective advan-
tage.
Correction of CNS Defects in MPSII Mice
Polito and Cosma, page 296
Deﬁciency of iduronate-2-sulfatase (IDS) causes mucopoly-
saccharidosis type II (MPSII), a disease characterized by
deposits of glycosaminoglycans (GAGs) in a variety of
tissues, leading to hepatosplenomegaly, cardiovascular
disorders, skeletal features, retinal and hearing problems,
and neurological deterioration. In concert with these
phenotypes, affected individuals also excrete high levels
of GAGs in their urine. The mouse model for MPSII shares
many of the same features with people affected by MPSII
and has served as an important resource for evaluation of
various treatment options. Previous gene-therapy work
with a vector carrying human IDS has successfully treated
many aspects of the disease, but because the therapy
cannot pass the blood-brain barrier (BBB), the neurological
defects are difﬁcult to treat with such methods. Here,
Polito and Cosma modify the vector used, in an effort to
establish a therapy that can cross the BBB to rescue the
CNS effects of MPSII while also treating the effects to
other organs. With a single injection of this new vector,
the authors are able to correct all aspects of MPSII in the
mouse model for more than 18 months. The authors
demonstrate that the accumulation of GAGs in all tissues
is ameliorated and that the level excreted in the urine
also returns to normal. Additionally, signs of neurodegen-
eration are cleared and the mice show improvement in
their gross motor skills. Importantly, the authors provide
evidence that demonstrates that the correction of the
CNS defects is most likely due to the established crossing
of the therapy across the BBB.14, 2009
